JPMorgan Chase

Marotta Asset Management Makes New Investment in Ameriprise Financial, Inc. $AMP

Marotta Asset Management has initiated a new investment in Ameriprise Financial (NYSE: AMP), acquiring 27,318 shares valued at approximately $13.45 million, representing 2.2% of its portfolio. This move comes as institutional investors collectively own a significant 83.95% of AMP. The financial services provider recently reported strong quarterly earnings, exceeding estimates with an EPS of $11.07 and an 11.6% increase in revenue, and has authorized a $5.5 billion share-repurchase plan.

42,057 Old Dominion Freight Line, Inc. $ODFL Shares Purchased by CX Institutional

CX Institutional significantly increased its stake in Old Dominion Freight Line, Inc. ($ODFL) by over 4,400% in the third quarter, acquiring 42,057 additional shares, bringing their total holdings to 43,012 shares valued at approximately $7.48 million. Other institutional investors also adjusted their positions, with institutional ownership now at 77.82%. The company reported strong quarterly earnings, exceeding EPS and revenue estimates, and analysts maintain a mixed "Hold" rating with an average price target of $226.35.

Wynn Al Marjan Island Project Remains on Track for 2027 Opening

Wynn Resorts is still targeting a September 2027 opening for its US$5.7 billion Wynn Al Marjan Island casino resort in Ras Al Khaimah, UAE, according to JP Morgan Securities. Despite recent regional tensions, the company remains confident in the project's prospects and potential for exclusivity. Additionally, Wynn Resorts is planning an expansion at its Macau property, The Enclave at Wynn Palace, to boost market share.

Sumitomo Mitsui Financial Group stock after-hours at EUR 22.50: plus 0.00 percent versus prior close

Sumitomo Mitsui Financial Group (SMFG) stock closed unchanged at EUR 22.50 after-hours on October 2, 2026, compared to its prior Lang & Schwarz close. The company also announced a share exchange agreement to make SMBC Nikko Securities an indirect SMFG subsidiary, with a new holding company overseeing its Japanese wholesale equities business, including a joint venture with Jefferies Financial Group.

StorageVault Canada (TSE:SVI) Stock Dropped to "Outperform" by Raymond James Financial

Raymond James Financial has downgraded StorageVault Canada (TSE:SVI) from a "strong buy" to an "outperform" rating, reducing its price target to C$5.25. Despite this, the consensus analyst rating remains a "Moderate Buy" with an average target of C$5.86. The company recently reported a quarterly loss of C$0.02 per share, and an insider recently purchased 89,700 shares.

JPMorgan Chase & Co. Cuts Columbia Banking System (NASDAQ:COLB) Price Target to $33.00

JPMorgan Chase & Co. has lowered its price target for Columbia Banking System (NASDAQ:COLB) to $33.00 from $35.00, while maintaining a "neutral" rating, implying a potential upside of 17.71%. This adjustment comes despite Columbia Banking System reporting quarterly earnings per share of $0.76, exceeding the consensus estimate of $0.73, though revenue fell short of expectations. The consensus among analysts remains a "Hold" rating with an average target price of $33.42, reflecting cautious sentiment, with five analysts rating it a "Buy" and eight a "Hold."

Brown & Brown (NYSE:BRO) Given New $83.00 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. has increased its price target for Brown & Brown (NYSE:BRO) to $83.00 from $80.00, maintaining a "neutral" rating and suggesting a 34.05% upside. This adjustment comes despite the financial services provider slightly missing earnings and revenue expectations in its latest quarterly report, although revenue grew by 30.4% year-over-year. The stock currently holds a "Hold" consensus rating with an average price target of $76.80 from analysts.

My Personal History Chapter 1

Stephen Schwarzman, co-founder of Blackstone, reflects on the early struggles of his firm and credits Japanese capital for its survival and growth into the world's largest alternative asset manager. He discusses his commitment to serving his country through economic advice to U.S. Presidents and his personal connection to Japanese leaders like former Prime Minister Shinzo Abe. Schwarzman outlines his intention to repay his debt to Japan by investing in its growth, guided by his personal mottos of "a better tomorrow" and "learn every day."

JPMorgan Adjusts Weyerhaeuser Price Target to $24 From $28

JPMorgan has lowered its price target for Weyerhaeuser (NYSE: WY) from $28 to $24, according to a report published on September 30, 2026. This adjustment follows other recent analyst price target changes for Weyerhaeuser, with some increasing and others decreasing their targets while maintaining various ratings. Weyerhaeuser's stock was trading at $19.40 at 12:13:19 pm EDT on September 30, 2026.

JPMorgan Group Exits Substantial Holder Position in Minerals 260

JPMorgan Chase and its affiliates have informed Minerals 260 that they no longer hold a substantial stake in the company's ordinary shares. This change is attributed to complex securities lending and trading adjustments, which will reshape Minerals 260’s institutional share register. The move does not directly impact the company's operations or strategy.

Artrya Limited Subject to Initial Substantial Holder Notice from State Street Corporation

State Street Corporation and its named subsidiaries have filed an initial substantial holder notice for Artrya Limited (ASX:AYA), disclosing a 5.02% voting power as of September 25, 2026. This relevant interest, totaling 8,196,320 ordinary securities, is held across various entities, including State Street Bank and Trust Company and State Street Global Advisors, Australia, Limited, through different types of relevant interests. The filing was submitted on September 29, 2026, under the Corporations Act 2001.

Citigroup Issues Pessimistic Forecast for Packaging Corporation of America (NYSE:PKG) Stock Price

Citigroup has lowered its price target for Packaging Corporation of America (NYSE:PKG) from $254 to $253, while maintaining a "neutral" rating. Despite this, the broader analyst consensus remains a "Moderate Buy" with an average price target of $271. The company recently surpassed quarterly EPS estimates and saw its revenue increase by 14.7% year-over-year.

Hewlett Packard Enterprise (NYSE:HPE) Shares Climb 1.1% on Analyst Upgrade

Hewlett Packard Enterprise (HPE) shares rose 1.1% after Citigroup raised its price target from $76 to $92, maintaining a Buy rating. The company secured a $1.2 billion order for AMD Helios AI Rack systems and increased its long-term networking revenue outlook due to growing AI infrastructure demand. Despite positive quarterly results, insider stock sales and valuation risks remain concerns.

Bank Stocks Slide as Money-Center Names Lead Financials Lower: Citigroup Falls 4%, Bank of America Drops 3%, JPMorgan Chase Slips

10,144 Shares in Apple Inc. $AAPL Bought by Veratis Advisors Inc.

Veratis Advisors Inc. recently purchased 10,144 shares of Apple Inc. (NASDAQ:AAPL) worth approximately $2.94 million, making it their ninth-largest holding. Institutional investors continue to show strong interest in Apple, with 67.73% of the stock owned by hedge funds and other institutions. Apple exceeded analyst expectations in its latest quarterly earnings report and maintains a "Moderate Buy" consensus rating with an average price target of $340.14.

Should You Buy Moderna Stock? Why Many Wall Street Analysts Say "No."

Moderna's stock has seen a significant surge due to positive clinical trial data for its mRNA-based cancer vaccine, co-developed with Merck. Despite this, many Wall Street analysts maintain a neutral or "hold" rating, with some downgrading the stock, believing the market has overreacted and that future trial results or immediate economic impacts are uncertain. Investors are advised to be cautious, with some experts suggesting waiting for the hype to subside before making long-term commitments, especially given recent share dilution through convertible debt.

Guggenheim raises BlossomHill Therapeutics price target to $40 on pipeline progress By Investing.com

Guggenheim has increased its price target for BlossomHill Therapeutics (NASDAQ: BLSM) to $40 from $30, maintaining a Buy rating, following promising pipeline advancements for its lead asset BH-30643 in lung cancer treatment. The company also reported strong Q2 2026 results and has a robust cash position, with $95 million in cash and equivalents and $168 million from its August 2026 IPO, extending its cash runway beyond major clinical readouts. JPMorgan also initiated coverage with an Overweight rating and a $28 price target, indicating growing confidence in the company's potential.